U S PHYSICAL THERAPY INC /NV

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $20.6m
$22.3m +8.30%
$34.9m +56.69%
$40.0m +14.81%
$35.2m -12.10%
$40.8m +16.02%
$32.2m -21.24%
$28.2m -12.19%
$31.4m +11.28%
$39.6m +25.96%
Net Income (Loss) Available to Common Stockholders, Basic $26.3m
$27.5m +4.61%
$28.3m
$14.7m -48.09%
$26.5m +80.32%
$15.1m -43.08%
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $26.3m $27.7m $48.8m $57.3m $52.5m $57.9m $43.4m $37.2m $45.6m $58.0m
Net Income (Loss) Attributable to Noncontrolling Interest $5.7m $5.5m $14.0m $17.2m $17.3m $17.1m $11.2m $9.0m $14.2m $18.4m
Depreciation, Depletion and Amortization $8.8m $9.7m $9.8m $10.1m $10.5m $11.6m $14.7m $15.7m $18.7m $22.4m $22.4m
Amortization of Debt Issuance Costs $56k $305k $420k $422k $422k
Amortization of Intangible Assets $2.4m $2.7m $2.8m $3.0m $3.4m $3.7m $6.5m $7.3m $9.5m $11.3m
Depreciation Amortization Depletion $14.7m $15.7m $18.7m $22.4m $22.4m
Deferred Income Tax Expense (Benefit) $3.0m ($4.9m) $4.8m $4.7m ($258k) $5.7m $12.4m $4.6m $4.9m $10.6m $9.4m
Deferred Income Tax $4.3m $4.5m $5.4m $11.4m $9.4m
Deferred Tax $4.3m $4.5m $5.4m $11.4m $9.4m
Share-based Payment Arrangement, Noncash Expense $5.0m $5.0m $5.9m $7.0m $7.9m $7.9m $7.3m $7.2m $7.8m $8.3m $9.9m
Share-based Payment Arrangement, Expense $7.2m $9.9m
Goodwill and Intangible Asset Impairment $0 $9.1m $17.5m $0 $0
Goodwill, Impairment Loss $1.9m $0 $9.1m $15.8m $0 $0 $0
Asset Impairment Charge $9.1m $17.5m $2.4m $0 $0
Income (Loss) from Equity Method Investments $112k $1.2m $955k $1.0m $1.5m
Nonoperating Income (Expense) $13.1m $2.5m ($1.2m) ($2.7m) ($3.0m) ($8.9m)
Other Nonoperating Income (Expense) $390k $357k $458k
Earnings (Loss)es From Equity Investments ($1.2m) ($955k) ($1.0m) ($1.5m) ($1.5m)
Changes in operating assets and liabilities:
Change In Working Capital ($21.7m) ($4.9m) ($12.4m) ($27.2m) ($18.5m)
Increase (Decrease) in Accounts Receivable $3.3m $3.4m $3.4m $6.4m ($899k) $9.4m $10.3m $5.6m $5.3m $12.0m ($11.2m)
Change In Receivables ($10.6m) ($6.0m) ($11.9m) ($9.1m) ($11.2m)
Changes In Account Receivables ($10.3m) ($5.6m) ($5.3m) ($12.0m) ($11.2m)
Change In Payables And Accrued Expense ($7.8m) $15k $1.7m ($7.8m) ($1.3m)
Change In Other Current Assets ($5.9m) ($197k) ($818k) ($10.4m) ($5.9m)
Change In Other Current Liabilities $2.5m $1.3m ($1.4m) $86k ($48k)
Net Cash Provided by (Used in) Operating Activities $51.0m
$56.5m +10.73%
$73.0m +29.15%
$62.4m -14.46%
$100.0m +60.13%
$76.4m -23.59%
$58.5m -23.39%
$82.0m +40.04%
$74.9m -8.59%
$75.1m +0.16%
$83.0m +10.65%
Cash flows from investing activities:
Gain (Loss) on Disposition of Property Plant Equipment $643k ($166k) ($836k) ($383k) ($1.2m)
Capital Expenditure ($8.2m) ($9.3m) ($9.2m) ($14.1m) ($19.0m)
Payments to Acquire Businesses, Net of Cash Acquired $23.6m $36.7m $16.4m $30.6m $23.9m $86.8m $59.8m $26.6m $133.1m $15.7m ($47.0m)
Payments for (Proceeds from) Other Investing Activities ($321k) ($694k) ($364k)
Net Other Investing Changes $321k $694k $895k $882k
Net Cash Provided by (Used in) Investing Activities ($32.5m) ($43.6m) ($23.9m) ($38.0m) ($51.2m) ($124.1m) ($81.3m) ($45.0m) ($149.4m) ($36.7m) ($63.6m)
Cash flows from financing activities:
Repayments of Long-term Debt $1.9m $3.8m $3.8m $9.4m ($254.4m)
Gain (Loss) on Extinguishment of Debt $1.8m $0 $0
Proceeds from Issuance of Long-term Debt $150.0m $0 $0 $314.9m
Issuance Of Debt $251.0m $24.0m $19.0m $189.5m $314.9m
Long Term Debt Issuance $251.0m $24.0m $19.0m $189.5m $314.9m
Long Term Debt Payments ($186.8m) ($63.1m) ($14.7m) ($181.4m) ($254.4m)
Net Issuance Payments Of Debt $64.2m ($39.1m) $4.3m $8.1m $60.4m
Net Long Term Debt Issuance $64.2m ($39.1m) $4.3m $8.1m $60.4m
Repayment Of Debt ($186.8m) ($63.1m) ($14.7m) ($181.4m) ($254.4m)
Payments for Repurchase of Common Stock $0 $0 $5.6m
Payments of Ordinary Dividends, Common Stock $8.5m $10.1m $11.7m $14.6m $4.1m $18.8m $21.3m $24.1m $26.5m $27.4m ($27.6m)
Proceeds from Issuance of Common Stock $0 $0 $163.6m $0 $0 $0
Common Stock Dividend Paid ($21.3m) ($24.1m) ($26.5m) ($27.4m) ($27.6m)
Common Stock Issuance $0 $163.6m $0 $0 $0
Common Stock Payments $0 $0 ($5.6m) ($24.8m)
Issuance Of Capital Stock $0 $163.6m $0 $0 $0
Repurchase Of Capital Stock $0 $0 ($5.6m) ($24.8m)
Cash Dividends Paid ($21.3m) ($24.1m) ($26.5m) ($27.4m) ($27.6m)
Dividends Received CFI $1.3m $830k $1.1m $1.4m $1.1m
Proceeds from (Payments for) Other Financing Activities $1k $161k ($42k) ($52k) $2k $28k $12k $0 $0
Net Other Financing Charges ($17.1m) ($16.1m) ($14.7m) ($19.3m) ($36.8m)
Net Cash Provided by (Used in) Financing Activities ($14.3m)
($11.1m) +22.56%
($47.7m) -330.74%
($24.3m) +49.07%
($39.4m) -62.40%
$43.4m +210.04%
$25.8m -40.62%
$84.3m +227.14%
($37.0m) -143.85%
($44.1m) -19.44%
($28.7m) +35.06%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4.3m $1.9m $1.4m $180k $9.4m ($4.4m) $3.0m $121.2m ($111.5m) ($5.8m) $24.9m
Beginning Cash Position $28.6m $31.6m $152.8m $41.4m $34.1m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23.5m $32.9m $28.6m $31.6m $152.8m $41.4m $35.6m $24.9m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $784k $2.1m $2.4m $1.9m $1.2m $1.4m $5.7m $8.7m $7.2m $9.4m
Income Taxes Paid, Net $10.6m $8.5m $9.2m $9.9m $7.7m $12.2m $7.6m $4.9m $4.8m $14.3m
Additional Financial Items
Gain (Loss) on Disposition of Business $100k
Goodwill $226.8m $271.3m $293.5m $317.7m $345.6m $434.7m $494.1m $509.6m $667.2m $692.4m $0
Income Tax Expense (Benefit) $11.9m $6.0m $11.4m $13.6m $13.0m $15.3m $12.2m $12.2m $14.6m $19.8m
Investment Income, Interest $3.8m $3.9m $105k
Payments of Financing Costs $1.8m $0 $0
Proceeds from Noncontrolling Interests $138k $0 $914k $1.6m $4.1m $1.9m $0
Cash Flow From Continuing Financing Activities $25.8m $84.3m ($37.0m) ($44.1m) ($28.7m)
Cash Flow From Continuing Investing Activities ($81.3m) ($45.0m) ($149.4m) ($36.7m) ($63.6m)
Change In Cash Supplemental As Reported $3.0m $121.2m ($111.5m) ($5.8m)
Changes In Cash $3.0m $121.2m ($111.5m) ($5.8m) ($9.2m)
End Cash Position $31.6m $152.8m $41.4m $35.6m $24.9m
Financing Cash Flow $25.8m
$84.3m +227.14%
($37.0m) -143.85%
($44.1m) -19.44%
($28.7m) +35.06%
Free Cash Flow $50.3m $72.7m $65.8m $61.0m $64.1m
Gain Loss On Sale Of Business $0 $0 $0
Gain Loss On Sale Of PPE ($643k) $166k $836k $383k $247k
Investing Cash Flow ($81.3m) ($45.0m) ($149.4m) ($36.7m) ($63.6m)
Net Business Purchase And Sale ($74.3m) ($36.9m) ($142.0m) ($24.9m) ($46.6m)
Net PPE Purchase And Sale ($8.2m) ($9.3m) ($9.2m) ($14.1m) ($19.0m)
Operating Gains Losses ($1.8m) ($789k) ($178k) ($1.1m) ($1.2m)
Other Non Cash Items ($2.3m) ($612k) $723k ($4.4m)
Provisionand Write Offof Assets $5.5m $6.2m $6.9m $7.6m $7.9m
Purchase Of Business ($75.1m) ($37.8m) ($142.1m) ($25.9m) ($47.0m)
Purchase Of PPE $8.3m $7.1m $7.2m $10.2m $7.6m $8.2m ($8.2m) ($9.3m) ($9.2m) ($14.1m) ($19.0m)
Sale Of Business $775k $977k $105k $916k $463k
Stock Based Compensation $7.3m $7.2m $7.8m $8.3m $9.9m